| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer
1 company
Dirk G. Brockstedt is Chief Scientific Officer at RAPT. Dirk G. Brockstedt's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Historically, Dirk G. Brockstedt's trades have earned a strong insider score of 71/100 across 16 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +24.0%.
Dirk G. Brockstedt has 34 Form 4 filings on record from January 2020 to March 2026, all as Chief Scientific Officer at RAPT Therapeutics (RAPT), 2020–2026.
The 74 reported transactions were 24 open-market sales, 20 option exercises, 15 dispositions back to the company and 12 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 22 sales worth about $1.8M.
The largest open-market sale was 9,877 shares of RAPT at an average $23.93 on August 17, 2020, about $236K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sell | 898 | $22.78 | $20,456.44 | -3.1% | -65.8% | -92.9% | |
| Jan 5, 2023 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sell | 742 | $21.97 | $16,298.77 | -3.7% | -27.0% | +3.5% | |
| May 4, 2022 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sell | 720 | $15.05 | $10,836.00 | -3.5% | +24.6% | +22.9% | |
| Apr 11, 2022 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,647 | $23.05 | $61,013.35 | -11.8% | -10.0% | -27.0% | |
| Mar 11, 2022 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,648 | $23.91 | $63,313.68 | -11.8% | -34.1% | +3.0% | |
| Feb 11, 2022 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,647 | $22.47 | $59,478.09 | -11.8% | -44.2% | +24.0% | |
| Jan 11, 2022 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,648 | $32.16 | $85,159.68 | -11.8% | -33.7% | -24.2% | |
| Dec 10, 2021 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,647 | $30.88 | $81,739.36 | -11.8% | -20.2% | -43.1% | |
| Nov 11, 2021 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,648 | $35.69 | $94,507.12 | -11.8% | -37.5% | -35.6% | |
| Oct 11, 2021 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,647 | $30.78 | $81,474.66 | -11.8% | +6.8% | -28.1% |